|
PRPF8 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.566600E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.172410E-01 |
| Normal-vs-Stage2 |
2.157900E-03 |
| Normal-vs-Stage3 |
5.17799999988355E-07 |
| Normal-vs-Stage4 |
1.83977000000057E-05 |
| Stage1-vs-Stage2 |
4.214200E-02 |
| Stage1-vs-Stage3 |
4.94500000003395E-06 |
| Stage1-vs-Stage4 |
4.350800E-04 |
| Stage2-vs-Stage3 |
2.269600E-01 |
| Stage2-vs-Stage4 |
3.801400E-01 |
| Stage3-vs-Stage4 |
7.572000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.194400E-04 |
| Normal-vs-AfricanAmerican |
4.544200E-03 |
| Normal-vs-Asian |
9.709600E-01 |
| Caucasian-vs-AfricanAmerican |
6.875600E-01 |
| Caucasian-vs-Asian |
2.501600E-01 |
| AfricanAmerican-vs-Asian |
2.197000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.197000E-04 |
| Normal-vs-Female |
1.604140E-02 |
| Male-vs-Female |
9.982300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.645570E-02 |
| Normal-vs-Age(41-60Yrs) |
7.422300E-03 |
| Normal-vs-Age(61-80Yrs) |
7.767900E-04 |
| Normal-vs-Age(81-100Yrs) |
2.394700E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.525600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.848800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.836000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.853800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.046000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.089700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.933400E-01 |
| Normal-vs-Grade 2 |
7.154200E-02 |
| Normal-vs-Grade 3 |
1.172820E-04 |
| Normal-vs-Grade 4 |
2.83629999486834E-08 |
| Grade 1-vs-Grade 2 |
1.035620E-01 |
| Grade 1-vs-Grade 3 |
7.379300E-03 |
| Grade 1-vs-Grade 4 |
1.025960E-04 |
| Grade 2-vs-Grade 3 |
5.023700E-03 |
| Grade 2-vs-Grade 4 |
3.98639999998895E-06 |
| Grade 3-vs-Grade 4 |
1.210380E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
4.618000E-01 |
| Normal-vs-ccB subtype |
2.08239999999194E-05 |
| ccA subtype-vs-ccB subtype |
1.23990000000518E-06 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.122920E-03 |
| Normal-vs-N1 |
3.477600E-02 |
| N0-vs-N1 |
6.951400E-01 |
|
|
